Lv1
10 积分 2026-03-03 加入
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
待确认
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
3个月前
已完结
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
3个月前
已完结
皖公网安备34019202002308
